baber/WOPTO huggingface dataset:
Patent FI-954612-A0 (FI)
Inventor: CLAUSSNER ANDRE
IPC: C07D495/10
Filed: 1995-09-28
Abstract: Imidazolidines of formula (I) in racemic, enantiomeric and diasteroisomeric forms, and their salts are new. In (I) ring is e.g. satd. heterocycle of 4-7 members contg. either O, N, S (opt. oxidised), and opt. substd. by a group selected from R3; Ar is e.g. aryl (opt. substd. by halo, CN, NO2, CF3, CF3O, OH, COOH or salified, esterified, or amidified COOH) or a gp. (ii) in which N is opt. oxidised and R1 and R2 are H or (substd.) alkyl, or form with N atom e.g. 5, 6 or 7 membered monocyclic ring opt. contg. other heteroatoms (O, N, S) and opt. substd. etc.; X is O or S; Y is O, S or NH; R3 is H, aryl, alkyl, alkenyl, alkynyl, opt. interrupted by one or more O, N, or S (opt. oxidised) atoms, and opt. substd.
Patent FI-963095-A0 (FI)
Inventor: FITZGERALD KEVIN A
IPC: B65H75/16
Filed: 1996-08-06
Abstract: A reloadable film canister system provides light-tight and dust-free enclosure for 105 mm microfilm and the like. A gear-toothed reel inside the canister (125) meshes with a gear assembly (130, 132, 141, 142) of the canister (125) and linearly drives a detectable element (149) adjacent a sensing element located in a host machine. <IMAGE>
Patent FI-971430-A0 (FI)
Inventor: WATSON ANDREW
IPC: H04W36/04
Filed: 1997-04-04
Abstract: A method of performing a handover as shown in FIGS. 2-3 for a mobile station in a multicellular environment including the steps of determining to handover from one of the plurality of microcells to the macrocell, performing handover from the one of the plurality of microcells to the macrocell; and sending a false neighbor list to the mobile station.
Patent FI-991064-A0 (FI)
Inventor: SIEVAENEN MIKKO
IPC: A63D1/00
Filed: 1999-05-10
Abstract: The invention relates to a substructure of a bowling lane, which comprises a framework composed of beams (1, 2, 3). The horizontally installed beams (1, 2) of the substructure have first and second fixing means (FE, SE) and beams (1, 2) are attached together by connecting the first and second fixing means (FE, SE) of the beams (1, 2).
Patent IL-69897-A0 (IL)
Title: Human pancreatic grf analogs
IPC: A61K38/07
Filed: 1983-10-04
Abstract: Two surprisingly active fragments of human pancreatic GRF have been synthesized, along with an analog which exhibits good biological activity. The synthetic peptides are extremely potent in stimulating the release of pituitary GH in humans and nonhuman animals and have the general formula:
 H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-R15-Gln-Leu-Ser-Ala-Ar g-Lys-Leu-Leu-Gln-Asp-lle-Met-Ser-Arg-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-R40-Y wherein R15 is Gly or D-Ala, R40 is Ala or des-R40 and Y signifies the carboxyl moiety of the amino acid residue at the C-terminal and is the radical -COOR1, -CR1O, -CONHNHR1, -CON(R1)(R2) or -CH2OR1, with R1 and R2 being lower alkyl or hydrogen. The two fragments include the 29 or 32 N-terminal residues and are each amidated at the C-terminus. These peptides, as well as nontoxic salts thereof, may be administered therapeutically to animals, including humans.
Patent IL-71876-A0 (IL)
Title: Process for the preparation of optically active carbazole derivatives,new r-and s-carbazole derivatives and pharmaceutical compositions containing these compounds
IPC: C07D209/56
Filed: 1984-05-26
Abstract: A process for the preparation of S- or R-carbazole derivatives of the general formula:   <IMAGE>   in which R is an unsubstituted or substituted amino radical and pharmacologically acceptable salts, by either reacting R-(-)-epichlorohydrin (for the S-carbazole derivative); or reacting an S-epoxide derivative of the general formula:   <IMAGE>   in which R1 is the residue of a substituted sulphonic acid derivative (for the R-carbazole derivative); with 4-hydroxycarbazole and then with ammonia or a substituted amine of the general formula RH, and recovering the compound or converting it to a pharmacologically acceptable salt. The new R-(+)- and S-(-)-carbozole derivatives provided by the inventive process have unexpected beta blocking and vasodilatory properties and are useful in pharmaceutical compositions. R-(+)-carbazole derivatives are also useful for the treatment of glaucoma.
Patent IL-73521-A0 (IL)
Title: Preparation of intermediate compounds for the synthesis of nucleosides and certain such novel compounds
IPC: C07H13/00
Filed: 1984-11-15
Abstract: Process for producing 1-halo-2-deoxy-2-fluoroarabi- nofuranoside derivatives bearing protective ester groups from 1,3,5-tri-O-acylribofuranose; the 1-halo compounds are intermediates in the synthesis of therapeutically active nucleosidic compounds.
Patent IL-81931-A0 (IL)
Title: Mixer drive apparatus
IPC: B01F7/00
Filed: 1987-03-18
Abstract: Mixer drive apparatus, which provides gear reduction for driving the impeller shaft of the mixer. A drive shaft (22) from an electric motor (18) is parallel to the impeller shaft (34) which extends through a support collar of a housing where the collar has a hole therethrough into which the impeller shaft extends into the housing. A hub (38) is rotatably mounted on the outside of the housing (10) and carries a gear (42) which is coupled to a pinion on the motor drive shaft. A coupling (70) is attached to the hub and bridges the hole in the collar. The end of the impeller shaft is cantilevered and overhung from the coupling. A gap is defined between the impeller shaft and the inside surface of the support collar which is adapted to receive a seal assembly. The seal assembly (30) includes a retainer hub which captures a sleeve containing the seal structure in the gap between the coupling and the retainer. The seal sleeve (40) may readily be removed upon disassembly of the coupling, which has two sections defining a split ring which clamps the upper end of the impeller shaft, and has a thrust plate with a bolt therethrough into the end of the impeller shaft for axially adjusting the location of the shaft so as to bring the seal sleeve into engagement with the coupling for rotation therewith. A support collar on the impeller shift engages the retaining hub when the coupling releases the shaft for the removal and replacement of the seal sleeve assembly. A seal captured by the collar engages the retainer hub and provides a pressure seal to facilitate replacement of the seal sleeve when the mixer is used with a pressurized vessel.
Patent IL-84228-A0 (IL)
Title: Electronic equipment for control of fluorescent lamps
IPC: H05B41/391
Filed: 1987-10-20
Abstract: A device for producing alternating electric current of high frequency for power consumers such as fluorescent tubes (Ly1, Ly2) comprises a transformer with a winding (n3) connected in series with an output terminal (e) and active electronic components such as transistors (T1, T2) controlling the output current, the transistors being controlled by electric voltages produced by inductive feedback in feedback windings (n11, n12). Magnetic saturation is utilized to modify the inductive relationship in such a way that the transistors (T1, T2) cyclically change the direction of the output current. The feedback takes place in two magnetic cores (Tr1, Tr2) of the transformer, each core being provided with at least one further electric magnetization winding designated a command winding (n5, n6) as electric current is fed through the command windings to control magnetic saturation of the magnetic cores (Tr1, Tr2). As a result, combined control of the frequency and of the active electric power in the fluorescent tubes (Ly1, Ly2) is possible so that the luminous power may be controlled over a wide range while suitably high voltages can be maintained to ignite the tubes properly.
Patent IL-91639-A0 (IL)
Title: Method for determining preeclampsia,pregnancy induced hypertension or eclampsia,a reagent and kit for use therewith
IPC: G01N33/50
Filed: 1989-09-14
Abstract: Preeclampisa, pregnancy induced hypertension (PIH) and eclampsia are determined by identifying the presence of an endothelial cell marker in a sample of blood, plasma or serum of a pregnant woman using a sandwich or competition immunoassay. Cellular fibronectin marker in a sample is determined by binding with an anti-(cellular fibronectin) antibody. Reagents for these methods are also an aspect of the invention.
Patent FI-20001553-A0 (FI)
Inventor: BERGENWALL MARTIN
IPC: H04L12/721
Filed: 2000-06-29
Abstract: A method and a device for optimizing the routing of data packets, in which method data packets are received, data flow is detected on the received data packets, a feedback request is transmitted in response to the detected data flow, feedback information is received, feedback information is generated and added to the received feedback information, feedback information is transmitted and the data packets belonging to the data flow are directed on the basis of said feedback information.
Patent FI-20001697-A0 (FI)
Inventor: NYMAN BROR
IPC: B03D1/16
Filed: 2000-07-21
Abstract: The invention relates to a flotation mechanism (4) comprising a directional element (25) and vertical vanes (26) located in a flotation cell (2). The directional element is symmetrical and is fixed at the center to the lower section of the hollow shaft of the mechanism. According to the corresponding method, due to the directional element (25), which is cylindrically inclined downwards from the outer edge the flotation mechanism directs the gas-slurry suspension that is formed in a downward slanting direction towards the side wall of the cell. The mineral suspension rises upwards from the side wall towards the center of the cell, from where the flow is diverted to the edges of the cell and the froth generated is removed from the cell. Using this flotation mechanism enables a powerful agitation, extending throughout the entire mixing zone (I).
Patent FI-20021221-A0 (FI)
Inventor: VASSILIADIS STAMATIS
IPC: H03M7/42
Filed: 2002-06-20
Abstract: A method and associated decoder, system, device and storage means for decoding codewords of variable length from a bit stream, in which minimum and maximum lengths are defined for the codewords, wherein the bit stream is processed in parts, each part being subjected to a search for codewords, and where found codewords are decoded. At least partly overlapping fields are extracted from the bit stream part in such a way that the starting point of at least two fields is a possible starting point of a codeword in that part. In at least one field, the end of the codeword is searched, and the data related to the codeword is determined on the basis of the end point of the codeword. Data relating to at least one codeword is used to determine the occurrence of the codeword intended to be decoded in a field, and the found codeword is decoded.
Patent FI-20115374-A0 (FI)
Inventor: TAKKINEN KRISTIINA
IPC: C07K/
Filed: 2011-04-18
Abstract: The present invention provides mutant polypeptides useful as hypoallergens. More specifically the present invention provides mutant Bet v 1 proteins and the use of such polypeptides as hypoallergens for desensitizing against birch pollen allergies. Furthermore, the invention provides vaccine formulations comprising such polypeptides; the use of such formulations; and to methods of vaccination against birch pollen allergy.
Patent IL-109111-A0 (IL)
Title: 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
IPC: C07D413/12
Filed: 1994-03-24
Abstract: PCT No. PCT/US94/02803 Sec. 371 Date Sep. 22, 1995 Sec. 102(e) Date Sep. 22, 1995 PCT Filed Mar. 23, 1994 PCT Pub. No. WO94/22843 PCT Pub. Date Oct. 13, 1994Disclosed are compounds of the formula I wherein: Y represents -CO2H, -CO2R6, -C(O)NHR7, -SO2H, -SO3H, -SO3R6, -SO2NHR7, -C(O)-N(OH)-R8, or a group of the formula  or a pharmaceutically acceptable addition salt or solvate thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I. Further disclosed is a method for treating or preventing respiratory depression, epileptic seizures or other central nervous system disorders, and for enhancing cognitive performance, by administering an effective amount of a compound of Formula I.
Patent IL-126643-A0 (IL)
Title: Vitamin d derivatives with carbo- or heterocyclic substituents at c-25 process for their production and use for the production of pharmaceutical agents
IPC: C07D213/30
Filed: 1997-04-21
Abstract: Compounds of Formula I, wherein Y<SUB>1</SUB>, Y<SUB>2</SUB>, R<SUB>1</SUB>-R<SUB>6</SUB>, Q and Z are as defined herein, are vitamin D derivatives. These compounds are useful for, e.g., the treatment hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS, atopic skin conditions, secondary hyperparathyroidism, renal osteodystrophia, senile and postmenopausal osteoporosis, diabetes mellitus type II, degenerative diseases of the peripheral and central nervous system, hypercalcemias, granulomatous diseases, paraneoplastic hypercalcemias, hypercalcemias in hyperparathyroidism, hirsutism, ateriosclerosis, and/or inflammatory diseases.
Patent IL-131394-A0 (IL)
Title: Chromatographic purification of chlorinated sucrose
IPC: C07H1/06
Filed: 1998-02-11
Abstract: A process for separating, in the liquid phase, a reaction mixture which comprises a first chlorinated sucrose and at least one additional component selected from the group consisting of at least one other chlorinated sucrose different from said first chlorinated sucrose, salt and solvent, by injecting said reaction mixture onto a fixed bed of solid adsorbent and treating with a desorbent such that: (a) the first chlorinated sucrose passes through the adsorbent into a first recoverable product stream rich in said first chlorinated sucrose at a rate, which is different than the rate at which, (b) at least one of said additional components passes through the adsorbent into at least a second recoverable stream rich in said additional component.
Patent IL-146268-A0 (IL)
Title: Blood filter and method for treating vascular disease
IPC: A43B7/20
Filed: 2000-05-03
Abstract: A filter is provided that is convertible from a filter configuration to an open, stent-like configuration. The filter includes a plurality of intraluminal filter elements (filter legs) that may be formed into a single cone or dual cone filter structure. A retainer secures the filter legs in the filter configuration upon initial deployment within a vessel. The retainer is then either self-releasing or removable to permit the filter legs to expand from the filter configuration into what may generally be described as an open or stent-like configuration.
Patent IL-146439-A0 (IL)
Title: Process for delaying the deactivation of glutaryl amidase during enzyme catalysis
IPC: C12P35/02
Filed: 2000-05-13
Abstract: The present invention relates to a process for delaying the deactivation of glutaryl amidase during enzyme catalysis. The enzyme catalyst is, after maximum conversion of the substrate, separated off by filtration and can be reused in a subsequent reaction batch. In each reaction cycle, the enzyme catalyst loses activity. The inactivation of the enzyme catalyst can be delayed by bringing it into contact with a thiol during the reaction.
Patent IL-152773-A0 (IL)
Title: Oil-in-water emulsion
IPC: A61K47/04
Filed: 2001-05-22
Abstract: The invention relates to sterile pharmaceutical compositions for parenteral administration which comprise an oil-in-water emulsion in which a free radical scavenging sedative agent dissolved in an omega-3 rich water-immiscible solvent, is emulsified with water and stabilised by means for a surfactant, the composition being suitable either directly or after dilution with a liquid diluent for parenteral administration to a warm-blooded animal; in particular to such compositions comprising propofol, and which optionally further comprise a metal ion chelating agent (such as edetate), and the use of such compositions in improving survival in critically ill patients.
Patent IL-157041-A0 (IL)
Title: Monoclonal antibodies to the clfa protein and method of use in treating and preventing infections
IPC: C07K16/12
Filed: 2002-01-28
Abstract: Monoclonal antibodies which can bind to the ClfA protein and which are generated from binding subdomains or active fragments of the ClfA protein from Staphylococcus aureus, including the active fragments proteins from its fibrinogen binding domain such as Clf40 protein, the Clf33 protein, or ClfA N3, are provided which can be useful in the treatment and protection against infection from staphylococcal bacteria such as Staphylococcus aureus. In addition, medical instruments can be treated using the monoclonal antibodies of the invention in order to reduce or eliminate the possibility of their becoming infected or further spreading the infection. In particular, the antibodies of the present invention are advantageous because they can prevent adherence of the bacteria to host cells by impairing or inhibiting the ability of S. aureus ClfA to bind to fibrinogen or fibrin, and thus can be utilized in methods or treating or preventing staphylococcal inventions.
Patent IL-160937-A0 (IL)
Title: Lactic acid producing bacteria for use as a probiotic organisms in the human vagina
IPC: A61P15/02
Filed: 2002-09-19
Abstract: The present invention discloses novel isolated strains of lactic acid producing bacteria of the genera Lactobacillus and Pediococcus, and a method for isolation of such bacterial strains, having the ability to colonise and become established in a human vagina, even during menstrual discharge. Furthermore, a composition comprising said bacterial strains and a sanitary article comprising said bacterial strains, such as a tampon, for prophylaxis and/or treatment of infections of the urogenital tract, are described. The present invention also describes a method for prophylaxis and/or treatment of infections of the urogenital tract, wherein at least one of said bacterial strains are administered vaginally.
Patent IL-173934-A0 (IL)
Title: Energy recovery system
IPC: F01D25/16
Filed: 2006-02-26
Abstract: An energy recovery system, for extracting energy from a source of waste heat (e.g., hot waste fluid from small industrial installations, automotive combustion engines, etc.) the system being a closed Rankine cycle system with a circulating working fluid. The system comprises: a first heat exchanger for receiving source fluid, incorporating the waste heat, at a first temperature and outputting said waste fluid at a second temperature, and for receiving said working fluid at a third temperature and outputting the working fluid at a fourth temperature, said fourth temperature being higher than said third temperature and higher than the boiling point of the working fluid; a turbine unit, ranged to receive the working fluid output from the first heat exchanger at a first pressure and to output the working fluid at a second pressure, said second pressure being lower than the first pressure, the turbine unit thereby imparting rotational energy to a turbine shaft mounted within the turbine unit; an electromechanical conversion unit (including an alternator), coupled to the turbine shaft, for converting said rotational energy into electrical energy, a cooling system, coupled to the turbine unit and to the first heat exchanger, for receiving the working fluid from the turbine unit at a fifth temperature, cooling the fluid, and supplying the fluid to the first heat exchanger at said third temperature. A technique for controlling the output power of the alternator is also disclosed Special turbine, bearing, torque coupling, power control and working fluid purification techniques are also disclosed.
Patent IL-176214-A0 (IL)
Title: Methods for suppressing an immune response or treating a proliferative disorder
IPC: A61K31/496
Filed: 2006-06-08
Abstract: Disclosed herein are methods for suppressing an immune response in a subject, treating a neoplasm in a subject, or treating a fibroproliferative vascular disease in a subject, that includes administering to the subject a therapeutically effective amount of a 2-(4-piperazinyl)-substituted 4H-1-benzopyran-4-one compound, or a pharmaceutically acceptable salt thereof, having the structure of wherein the presence of each of R1 and R2 is optional and R1 and R2 are each independently selected from alkyl, substituted alkyl, heteroalkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, halogen, hydroxy, or amino.
Patent IL-196371-A0 (IL)
Title: Efficient process for purification of high molecular weight hyaluronic acid
Filed: 2009-01-06
Abstract: A process for purifying hyaluronic acid (HA) or its salt from a bacterial fermentation broth comprising: 
(a) diluting and clarifying the fermentation broth; 
(b) precipitating the HA present in the broth with an equal volume of solvent; 
(c) dissolving the precipitated HA or its salt in a solution; 
(d) adding silica gel to the HA solution or HA salt solution from step (c) and then removing the silica gel; 
(e) treating the HA solution or HA salt solution from step (d) with active carbon; and 
(f) diafiltrating the HA solution or HA salt solution from step (e) using about 5 volumes of solvent;  
wherein the process is conducted in the absence of any detergent or surfactant or formalin, and at neutral pH.
Patent IL-213523-A0 (IL)
Title: Compositions comprising blood group antigens
Filed: 2011-06-13
Abstract: The present invention provides compositions and methods for treating or preventing antibody mediated graft rejection and blood typing.
Patent RO-129896-A0 (RO)
Title: Micro thermal station with magnets
Inventor: MĂRIEŞ IONUŢ TUDOR
IPC: F24H1/12
Filed: 2013-12-16
Abstract: The invention relates to a micro thermal station which uses the principle of alternation of magnetic fields by copper, intended to provide hot water for consumption and heating in any type of buildings. According to the invention, the micro thermal station comprises a D.C. motor () which provides rotation of a magnetic wheel () on which permanent magnets () with the south pole facing upwards alternate with permanent magnets () with the north pole facing upwards, two heat exchangers () wherethrough water to be heated circulates being mounted above the magnetic wheel () and being connected at their top to some stabilizers () meant to ensure permanent smoothness and parallelism with the magnetic wheel (), the stabilizers, in their turn, being maintained in a stable position by another stabilizer (), the motion of the two heat exchangers () as related to the magnetic wheel () being provided by two stepper motors () by means of some screws (), the water circulation being enabled by two inlet flexible pipes () and two outlet flexible pipes (), while the temperature within the micro station is controlled by means of four thermometers (), where the cold water is pumped into the first heat exchanger () by means of a programmable pump () and into the second heat exchanger () by means of the pressure within the central system, controlled by an automatic valve (). The operation of the micro station is controlled by a control board () and, in case the station power supply from the power supply network fails, the operation is ensured by a back-up system ().
Patent RO-132433-A0 (RO)
Title: Direct and effective thermal method for synthesis of perovskite materials of the lacootype in air, from lanthanum and cobalt oxidic precursors
Inventor: ENACHE STANICA
IPC: C01F17/00
Filed: 2017-07-12
Abstract: The invention relates to a method of synthesis of LaCoO-type perovskite materials. According to the invention, the method comprises the thermal synthesis from solid state in air, starting from a predefined molar mixture of lanthanum and cobalt oxide as powder, having a grain size of 2...6 μ m, by controlled heating in air, at a constant rate of 1...3°K/min, to the synthesis temperature of 750...1000°C, for 8...12 h, to result in LaCoOperovskite powder with highly uniform grains as size, shape and composition, representing at least 98.7% of the total mass of the synthesis product.